The proceeds from the initial public offering will fund the clinical studies necessary for MIRA’s synthetic cannabis drug to receive approval from the …
Maryland Inno – Baltimore cannabis pharmaceutical company plans to go public on Nasdaq
The proceeds from the initial public offering will fund the clinical studies necessary for MIRA’s synthetic cannabis drug to receive approval from the …
